Screener
Agios Pharmaceuticals AGIO Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | June 30,2026 | December 31,2025 |
|---|---|---|
| Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value; 125,000,000 shares authorized; 75,821,241 shares issued and 59,604,830 outstanding at June 30, 2026, and 74,665,003 shares issued and 58,448,592 outstanding at December 31, 2025 | 76 | 75 |
| Additional paid-in capital | 2,591,745 | 2,555,037 |
| Accumulated other comprehensive (loss) income | (1,795) | 2,193 |
| Accumulated deficit | (761,519) | (561,705) |
| Treasury stock, at cost (16,216,411 shares at June 30, 2026 and December 31, 2025) | (802,486) | (802,486) |
| Total stockholders’ equity | 1,026,021 | 1,193,114 |
| Total liabilities and stockholders’ equity | $1,108,424 | $1,297,225 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's total equity?
- Agios Pharmaceuticals (AGIO) reported total equity of $1.03B in Q2 2026.
- How has Agios Pharmaceuticals's total equity changed year-over-year?
- Agios Pharmaceuticals's total equity decreased by 25.1% year-over-year, from $1.37B to $1.03B.
- What is the long-term trend for Agios Pharmaceuticals's total equity?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's total equity has grown at a 24.5% compound annual growth rate (CAGR), from $399.5M to $1.19B.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Agios Pharmaceuticals's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude